Promoter shareholding in Mangalam Drugs has decreased slightly YoY (-0.01%) while remaining unchanged QoQ, indicating a lack of confidence from insiders.

Institutional shareholding has remained flat, mirroring the sector averages where both Promoter and Institutional changes are at 0%, suggesting no new investments from smart money.

Public shareholding has increased by 1.04% YoY and QoQ, but this reactive behavior contrasts with the lack of action from Promoters and Institutions, indicating a potential misalignment in sentiment.